NYSE:STVN Stevanato Group (STVN) Stock Price, News & Analysis → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free STVN Stock Alerts €27.31 +0.09 (+0.33%) (As of 08:04 PM ET) Add Compare Share Share Today's Range€27.14▼€27.9550-Day Range€26.54▼€33.1552-Week Range€23.00▼€36.30Volume190,300 shsAverage Volume338,762 shsMarket CapitalizationN/AP/E Ratio46.29Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Stevanato Group alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 About Stevanato Group Stock (NYSE:STVN)Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.Read More STVN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STVN Stock News HeadlinesApril 23, 2024 | americanbankingnews.comStevanato Group (NYSE:STVN) Earns Equal Weight Rating from Morgan StanleyApril 23, 2024 | americanbankingnews.comStevanato Group (NYSE:STVN) Now Covered by BNP ParibasApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!April 22, 2024 | americanbankingnews.comStevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of "Moderate Buy" by AnalystsApril 14, 2024 | finance.yahoo.com11 Best Italian Stocks To Invest In 2024April 4, 2024 | finanznachrichten.deStevanato Group S.p.A.: Stevanato Group appoints Ugo Gay as Chief Operations OfficerApril 4, 2024 | finance.yahoo.comStevanato Group appoints Ugo Gay as Chief Operations OfficerApril 2, 2024 | sg.news.yahoo.comHere's the one place Microsoft thinks doesn't need Copilot AI integration across its Windows ecosystem after receiving backlashApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!April 1, 2024 | msn.comHere's Why Stevanato (STVN) Declined in Q4April 1, 2024 | finance.yahoo.comHere’s Why Stevanato (STVN) Declined in Q4March 29, 2024 | finance.yahoo.comHere’s Why Stevanato Group S.p.A. (STVN) Shares Sold Off in Q4March 27, 2024 | finance.yahoo.comStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesMarch 26, 2024 | businesswire.comStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters' Option to Purchase Additional Ordinary SharesMarch 22, 2024 | msn.comStevanato Group stock slides on pricing upsized stock offering to raise $330 millionMarch 21, 2024 | businesswire.comStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesMarch 20, 2024 | businesswire.comStevanato Group Announces Public Offering of Ordinary SharesMarch 12, 2024 | nz.finance.yahoo.comX-Men: The Animated Series Sequel Gets Release Date — Watch TrailerMarch 12, 2024 | insidermonkey.comShould You Hold Stevanato Group S.p.A. (STVN) for the Long-Term?March 11, 2024 | seekingalpha.comStevanato: Destocking And Valuation Risk (Rating Downgrade)March 11, 2024 | nz.finance.yahoo.comKate Middleton's Mother's Day Photo Isn't the Only Recent Family Snap Accused of PhotoshopMarch 11, 2024 | businesswire.comStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumMarch 10, 2024 | finance.yahoo.comStevanato Group S.p.A. (NYSE:STVN) Full-Year Results: Here's What Analysts Are Forecasting For This YearMarch 9, 2024 | seekingalpha.comStevanato Group S.p.A. (STVN) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finance.yahoo.comStevanato Group S.p.A. (NYSE:STVN) Q4 2023 Earnings Call TranscriptMarch 8, 2024 | finance.yahoo.comQ4 2023 Stevanato Group SpA Earnings CallMarch 8, 2024 | finance.yahoo.comStevanato Group Full Year 2023 Earnings: EPS Misses ExpectationsSee More Headlines Receive STVN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stevanato Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/07/2024Today4/24/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNYSE:STVN CUSIPN/A CIK1849853 Webwww.stevanatogroup.com Phone39049931811FaxN/AEmployees5,635Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€0.59 Trailing P/E Ratio46.41 Forward P/E Ratio40.87 P/E Growth2.93Net Income$157.62 million Net Margins13.43% Pretax Margin17.47% Return on Equity14.31% Return on Assets8.18% Debt Debt-to-Equity Ratio0.23 Current Ratio1.50 Quick Ratio1.06 Sales & Book Value Annual Sales$1.17 billion Price / SalesN/A Cash Flow€0.88 per share Price / Cash Flow31.08 Book Value€4.15 per share Price / Book6.60Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable Beta0.70 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Franco Stevanato (Age 51)Executive Chairman Mr. Franco Moro (Age 61)CEO & Director Mr. Marco Dal Lago (Age 51)Chief Financial Officer Mr. Ugo Gay (Age 59)Chief Operations Officer Mr. Lorenzo BendinelliChief Information OfficerMs. Lisa MilesSenior Vice President of Investor RelationsMr. Paolo De FabritiisChief HR OfficerMr. Mauro Stocchi (Age 58)Chief Business Officer Mr. Riccardo Butta (Age 59)President of Americas More ExecutivesKey CompetitorsNyxoahNASDAQ:NYXH180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWView All CompetitorsInstitutional OwnershipSeven Grand Managers LLCBought 59,100 shares on 4/23/2024Ownership: 0.000%Fifth Third BancorpBought 947 shares on 4/23/2024Ownership: 0.000%Raymond James & AssociatesBought 64,730 shares on 4/22/2024Ownership: 0.000%Norden Group LLCBought 32,032 shares on 4/19/2024Ownership: 0.000%Allspring Global Investments Holdings LLCSold 1,843 shares on 4/18/2024Ownership: 0.000%View All Institutional Transactions STVN Stock Analysis - Frequently Asked Questions Should I buy or sell Stevanato Group stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Stevanato Group in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STVN shares. View STVN analyst ratings or view top-rated stocks. How have STVN shares performed in 2024? Stevanato Group's stock was trading at €27.29 at the beginning of 2024. Since then, STVN shares have increased by 0.1% and is now trading at €27.31. View the best growth stocks for 2024 here. When is Stevanato Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our STVN earnings forecast. How were Stevanato Group's earnings last quarter? Stevanato Group S.p.A. (NYSE:STVN) announced its earnings results on Thursday, March, 7th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by $0.01. The company earned $320.60 million during the quarter, compared to analyst estimates of $326.85 million. Stevanato Group had a trailing twelve-month return on equity of 14.31% and a net margin of 13.43%. Stevanato Group's quarterly revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.19 earnings per share. How often does Stevanato Group pay dividends? What is the dividend yield for Stevanato Group? Stevanato Group declared an annual dividend on Wednesday, June 7th. Stockholders of record on Tuesday, June 6th will be paid a dividend of 0.0577 per share on Monday, July 17th. This represents a yield of 0.2%. The ex-dividend date of this dividend is Wednesday, June 7th. Read our dividend analysis for STVN. What ETF holds Stevanato Group's stock? Goldman Sachs Future Health Care Equity ETF holds 4,186 shares of STVN stock, representing 0.48% of its portfolio. What guidance has Stevanato Group issued on next quarter's earnings? Stevanato Group issued an update on its FY24 earnings guidance on Thursday, March, 7th. The company provided EPS guidance of €0.62-0.66 for the period, compared to the consensus estimate of $0.67. The company issued revenue guidance of €1.18-1.21 billion, compared to the consensus revenue estimate of $1.21 billion. When did Stevanato Group IPO? Stevanato Group (STVN) raised $720 million in an IPO on Friday, July 16th 2021. The company issued 32,000,000 shares at $21.00-$24.00 per share. Who are Stevanato Group's major shareholders? Stevanato Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Raymond James & Associates (0.00%), Allspring Global Investments Holdings LLC (0.00%), Seven Grand Managers LLC (0.00%), Norden Group LLC (0.00%), First Bank & Trust (0.00%) and Fifth Third Bancorp (0.00%). How do I buy shares of Stevanato Group? Shares of STVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:STVN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stevanato Group S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.